SoftBank’s SB Management subsidiary, Illumina and Novartis are backing a $375m PIPE supporting the deal, which values the proteomics technology provider at $1.23bn.

Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

Amgen will pay an initial $55m and up to $666m in cash subject to milestones.

US-listed pharmaceuticals company Merck to spin off Organon after acquisition

UK-based biopharmaceutical company raises $75m in IPO

NeuroPace to raise $75m on Nasdaq.

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.

The Echo Health Ventures, Alphabet and EmblemHealth-backed care provider has secured about $500m in total, with the completion of a series C extension round.